KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Exchange Rate Effect (2021 - 2025)

Historic Exchange Rate Effect for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Q3 2025 value amounting to $93000.0.

  • Ginkgo Bioworks Holdings' Exchange Rate Effect rose 36571.43% to $93000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $280000.0, marking a year-over-year increase of 36415.09%. This contributed to the annual value of -$281000.0 for FY2024, which is 5221.09% up from last year.
  • Ginkgo Bioworks Holdings' Exchange Rate Effect amounted to $93000.0 in Q3 2025, which was up 36571.43% from $186000.0 recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Exchange Rate Effect registered a high of $1.1 million during Q4 2022, and its lowest value of -$469000.0 during Q2 2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' median Exchange Rate Effect value was -$16000.0 (recorded in 2024), while the average stood at $21941.2.
  • Over the last 5 years, Ginkgo Bioworks Holdings' Exchange Rate Effect had its largest YoY gain of 1009090.91% in 2022, and its largest YoY loss of 98750.0% in 2022.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Exchange Rate Effect (Quarter) stood at -$11000.0 in 2021, then skyrocketed by 10090.91% to $1.1 million in 2022, then tumbled by 90.72% to $102000.0 in 2023, then plummeted by 171.57% to -$73000.0 in 2024, then soared by 227.4% to $93000.0 in 2025.
  • Its last three reported values are $93000.0 in Q3 2025, $186000.0 for Q2 2025, and $74000.0 during Q1 2025.